İçeriğe geç

Kalp ve Damar Cerrahisi (Çocuk)

Uygun Hemostaz (Kanamanın Durması)

Antifibrinolitik İlaçlar

Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. (yeni pencere açar)

Arnold DM, Fergusson DA, Chan AK, Cook RJ, Fraser GA, Lim W, Blajchman MA, Cook DJ.

Kaynak‎: Anesth Analg 2006;102(3):731-7.

İndeks‎: PubMed 16492820

DOI‎: 10.1213/01.ane.0000194954.64293.61

https://www.ncbi.nlm.nih.gov/pubmed/16492820 (yeni pencere açar)

A systematic review of the use of antifibrinolytic agents in pediatric surgery and implications for craniofacial use. (yeni pencere açar)

Basta MN, Stricker PA, Taylor JA.

Kaynak‎: Pediatr Surg Int 2012;28(11):1059-69.

İndeks‎: PubMed 22940882

DOI‎: 10.1007/s00383-012-3167-6

https://www.ncbi.nlm.nih.gov/pubmed/22940882 (yeni pencere açar)

Aprotinin, transfusions, and kidney injury in neonates and infants undergoing cardiac surgery. (yeni pencere açar)

Bojan M, Vicca S, Boulat C, Gioanni S, Pouard P.

Kaynak‎: Br J Anaesth 2012;108(5):830-7.

İndeks‎: PubMed 22362670

DOI‎: 10.1093/bja/aes002

https://www.ncbi.nlm.nih.gov/pubmed/22362670 (yeni pencere açar)

Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. (yeni pencere açar)

Chauhan S, Das SN, Bisoi A, Kale S, Kiran U.

Kaynak‎: J Cardiothorac Vasc Anesth 2004;18(2):141-3.

İndeks‎: PubMed 15073700

https://www.ncbi.nlm.nih.gov/pubmed/15073700 (yeni pencere açar)

Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease. (yeni pencere açar)

Chauhan S, Kumar BA, Rao BH, Rao MS, Dubey B, Saxena N, Venugopal P.

Kaynak‎: Ann Thorac Surg 2000;70(4):1308-12.

İndeks‎: PubMed 11081890

https://www.ncbi.nlm.nih.gov/pubmed/11081890 (yeni pencere açar)

Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery. (yeni pencere açar)

Graham EM, Atz AM, Gillis J, Desantis SM, Haney AL, Deardorff RL, Uber WE, Reeves ST, McGowan FX Jr, Bradley SM, Spinale FG.

Kaynak‎: J Thorac Cardiovasc Surg 2012;143(5):1069-76.

İndeks‎: PubMed 22075061

DOI‎: 10.1016/j.jtcvs.2011.08.051

https://www.ncbi.nlm.nih.gov/pubmed/22075061 (yeni pencere açar)

Intraoperative tranexamic acid in pediatric bloodless cardiac surgery. (yeni pencere açar)

Hasegawa T, Oshima Y, Maruo A, Matsuhisa H, Tanaka A, Noda R, Yokoyama S, Iwasaki K.

Kaynak‎: Asian Cardiovasc Thorac Ann 2014;22(9):1039-45.

İndeks‎: PubMed 24637029

DOI‎: 10.1177/0218492314527991

https://www.ncbi.nlm.nih.gov/pubmed/24637029 (yeni pencere açar)

The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery. (yeni pencere açar)

Lin CY, Shuhaiber JH, Loyola H, Liu H, Del Nido P, DiNardo JA, Pigula FA.

Kaynak‎: PLoS One 2015;10(5):e0126514.

İndeks‎: PubMed 25954976

DOI‎: 10.1371/journal.pone.0126514

https://www.ncbi.nlm.nih.gov/pubmed/25954976 (yeni pencere açar)

Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery. (yeni pencere açar)

Martin K, Breuer T, Gertler R, Hapfelmeier A, Schreiber C, Lange R, Hess J, Wiesner G.

Kaynak‎: Eur J Cardiothorac Surg 2011;39(6):892-7.

İndeks‎: PubMed 21115357

DOI‎: 10.1016/j.ejcts.2010.09.041

https://www.ncbi.nlm.nih.gov/pubmed/21115357 (yeni pencere açar)

Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome. (yeni pencere açar)

Martin K, Gertler R, MacGuill M, Mayr NP, Hapfelmeier A, Hörer J, Vogt M, Tassani P, Wiesner G.

Kaynak‎: Br J Anaesth 2013;110(4):615-21.

İndeks‎: PubMed 23213034

DOI‎: 10.1093/bja/aes430

https://www.ncbi.nlm.nih.gov/pubmed/23213034 (yeni pencere açar)

Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. (yeni pencere açar)

Miller BE, Tosone SR, Tam VK, Kanter KR, Guzzetta NA, Bailey JM, Levy JH.

Kaynak‎: Ann Thorac Surg 1998;66(2):535-40; discussion 541.

İndeks‎: PubMed 9725399

https://www.ncbi.nlm.nih.gov/pubmed/9725399 (yeni pencere açar)

Efficacy of tranexamic acid as compared to aprotinin in open heart surgery in children. (yeni pencere açar)

Muthialu N, Balakrishnan S, Sundar R, Muralidharan S.

Kaynak‎: Ann Card Anaesth 2015;18(1):23-6.

İndeks‎: PubMed 25566706

DOI‎: 10.4103/0971-9784.148316

https://www.ncbi.nlm.nih.gov/pubmed/25566706 (yeni pencere açar)

Comparative analysis of antifibrinolytic medications in pediatric heart surgery. (yeni pencere açar)

Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, Jaquiss RD, Welke KF, Peterson ED, Shah SS, Jacobs JP.

Kaynak‎: J Thorac Cardiovasc Surg 2012;143(3):550-7.

İndeks‎: PubMed 22264414

DOI‎: 10.1016/j.jtcvs.2011.06.048

https://www.ncbi.nlm.nih.gov/pubmed/22264414 (yeni pencere açar)

Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study. (yeni pencere açar)

Rozen L, Faraoni D, Sanchez Torres C, Willems A, Noubouossie DC, Barglazan D, Van der Linden P, Demulder A.

Kaynak‎: Eur J Anaesthesiol 2015;32(12):844-50.

İndeks‎: PubMed 26258658

DOI‎: 10.1097/EJA.0000000000000316

https://www.ncbi.nlm.nih.gov/pubmed/26258658 (yeni pencere açar)

Comparison of different doses of ε-aminocaproic acid in children for tetralogy of Fallot surgery: clinical efficacy and safety. (yeni pencere açar)

Sarupria A, Makhija N, Lakshmy R, Kiran U.

Kaynak‎: J Cardiothorac Vasc Anesth 2013;27(1):23-9.

İndeks‎: PubMed 22995453

DOI‎: 10.1053/j.jvca.2012.07.001

https://www.ncbi.nlm.nih.gov/pubmed/22995453 (yeni pencere açar)

Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation. (yeni pencere açar)

Verma YS, Chauhan S, Bisoi AK, Gharde P, Kiran U, Das SN.

Kaynak‎: Ann Card Anaesth 2010;13(2):110-5.

İndeks‎: PubMed 20442540

DOI‎: 10.4103/0971-9784.62935

https://www.ncbi.nlm.nih.gov/pubmed/20442540 (yeni pencere açar)

Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass. (yeni pencere açar)

Wesley MC, Pereira LM, Scharp LA, Emani SM, McGowan FX Jr, DiNardo JA.

Kaynak‎: Anesthesiology 2015;122(4):746-58.

İndeks‎: PubMed 25585004

DOI‎: 10.1097/ALN.0000000000000570

https://www.ncbi.nlm.nih.gov/pubmed/25585004 (yeni pencere açar)

Efficacy and safety of aprotinin in neonatal congenital heart operations. (yeni pencere açar)

Wilder NS, Kavarana MN, Voepel-Lewis T, Paugh T, Lee T, Ohye RG.

Kaynak‎: Ann Thorac Surg 2011;92(3):958-63.

İndeks‎: PubMed 21871283

DOI‎: 10.1016/j.athoracsur.2011.04.094

https://www.ncbi.nlm.nih.gov/pubmed/21871283 (yeni pencere açar)

The effect of preoperative tranexamic acid on blood loss after cardiac operations in children. (yeni pencere açar)

Zonis Z, Seear M, Reichert C, Sett S, Allen C.

Kaynak‎: J Thorac Cardiovasc Surg 1996;111(5):982-7.

İndeks‎: PubMed 8622323

https://www.ncbi.nlm.nih.gov/pubmed/8622323 (yeni pencere açar)

Rekombinant Aktive Faktör VII (rFVIIa)

Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery. (yeni pencere açar)

Agarwal HS, Bennett JE, Churchwell KB, Christian KG, Drinkwater DC Jr, He Y, Taylor MB.

Kaynak‎: Ann Thorac Surg 2007;84(1):161-8.

İndeks‎: PubMed 17588404

DOI‎: 10.1016/j.athoracsur.2007.02.051

https://www.ncbi.nlm.nih.gov/pubmed/17588404 (yeni pencere açar)

Pediatric off-label use of recombinant factor VIIa. (yeni pencere açar)

Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK.

Kaynak‎: Pediatrics 2009;123(3):1066-72.

İndeks‎: PubMed 19255041

DOI‎: 10.1542/peds.2008-1685

https://www.ncbi.nlm.nih.gov/pubmed/19255041 (yeni pencere açar)

Factor VII for excessive bleeding following congenital heart disease surgery. (yeni pencere açar)

Changlani DK, Devendaran V, Murmu UC, Ganesan S, Varghese R, Kumar RS.

Kaynak‎: Asian Cardiovasc Thorac Ann 2012;20(2):120-5.

İndeks‎: PubMed 22499956

DOI‎: 10.1177/0218492311433614

https://www.ncbi.nlm.nih.gov/pubmed/22499956 (yeni pencere açar)

Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. (yeni pencere açar)

Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE.

Kaynak‎: Paediatr Anaesth 2009;19(4):364-70.

İndeks‎: PubMed 19143947

DOI‎: 10.1111/j.1460-9592.2008.02905.x

https://www.ncbi.nlm.nih.gov/pubmed/19143947 (yeni pencere açar)

Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients. (yeni pencere açar)

Guzzetta NA, Russell IA, Williams GD.

Kaynak‎: Anesth Analg 2012;115(2):364-78.

İndeks‎: PubMed 22652310

DOI‎: 10.1213/ANE.0b013e31825aff10

https://www.ncbi.nlm.nih.gov/pubmed/22652310 (yeni pencere açar)

Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery? (yeni pencere açar)

Okonta KE, Edwin F, Falase B.

Kaynak‎: Interact Cardiovasc Thorac Surg 2012;15(4):690-4.

İndeks‎: PubMed 22811512

DOI‎: 10.1093/icvts/ivs309

https://www.ncbi.nlm.nih.gov/pubmed/22811512 (yeni pencere açar)

Cardiac surgery without blood products in a Jehovah's Witness child with factor VII deficiency. (yeni pencere açar)

Pérez-Ferrer A, Gredilla E, de Vicente J, Laporta Y.

Kaynak‎: J Cardiothorac Vasc Anesth 2012;26(4):651-3.

İndeks‎: PubMed 21924639

DOI‎: 10.1053/j.jvca.2011.07.012

https://www.ncbi.nlm.nih.gov/pubmed/21924639 (yeni pencere açar)

Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. (yeni pencere açar)

Pychyńska-Pokorska M, Pągowska-Klimek I, Krajewski W, Moll JJ.

Kaynak‎: J Cardiothorac Vasc Anesth 2011;25(6):987-94.

İndeks‎: PubMed 21835642

DOI‎: 10.1053/j.jvca.2011.05.012

https://www.ncbi.nlm.nih.gov/pubmed/21835642 (yeni pencere açar)

Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery. (yeni pencere açar)

Scott JP, Costigan DJ, Hoffman GM, Simpson PM, Dasgupta M, Punzalan R, Berens RJ, Tweddell JS, Stuth EA.

Kaynak‎: J Clin Anesth 2014;26(3):204-11.

İndeks‎: PubMed 24809789

DOI‎: 10.1016/j.jclinane.2013.10.015

https://www.ncbi.nlm.nih.gov/pubmed/24809789 (yeni pencere açar)

Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery. (yeni pencere açar)

Singh SP, Chauhan S, Choudhary M, Vasdev S, Talwar S.

Kaynak‎: Asian Cardiovasc Thorac Ann 2012;20(1):19-23.

İndeks‎: PubMed 22371937

DOI‎: 10.1177/0218492311432584

https://www.ncbi.nlm.nih.gov/pubmed/22371937 (yeni pencere açar)

Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant. (yeni pencere açar)

Tobias JD, Berkenbosch JW, Russo P.

Kaynak‎: Pediatr Crit Care Med 2003;4(1):49-51.

İndeks‎: PubMed 12656542

DOI‎: 10.1097/01.PCC.0000031472.55687.4E

https://www.ncbi.nlm.nih.gov/pubmed/12656542 (yeni pencere açar)

Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients. (yeni pencere açar)

Tobias JD, Simsic JM, Weinstein S, Schechter W, Kartha V, Michler R.

Kaynak‎: J Intensive Care Med 2004;19(5):270-3.

İndeks‎: PubMed 15358945

DOI‎: 10.1177/0885066604267783

https://www.ncbi.nlm.nih.gov/pubmed/15358945 (yeni pencere açar)

Recombinant activated factor VII in cardiac surgery: a systematic review. (yeni pencere açar)

Warren O, Mandal K, Hadjianastassiou V, Knowlton L, Panesar S, John K, Darzi A, Athanasiou T.

Kaynak‎: Ann Thorac Surg 2007;83(2):707-14.

İndeks‎: PubMed 17258029

DOI‎: 10.1016/j.athoracsur.2006.10.033

https://www.ncbi.nlm.nih.gov/pubmed/17258029 (yeni pencere açar)

Defining the role of recombinant activated factor VII in pediatric cardiac surgery: where should we go from here? (yeni pencere açar)

Warren OJ, Rogers PL, Watret AL, de Wit KL, Darzi AW, Gill R, Athanasiou T.

Kaynak‎: Pediatr Crit Care Med 2009;10(5):572-82.

İndeks‎: PubMed 19451849

DOI‎: 10.1097/PCC.0b013e3181a642d5

https://www.ncbi.nlm.nih.gov/pubmed/19451849 (yeni pencere açar)

Decreasing the need for transfusion: infant cardiac surgery using hemodilution and recombinant factor VIIa. (yeni pencere açar)

Winch PD, Naguib AN, Bradshaw JR, Galantowicz M, Tobias JD.

Kaynak‎: Pediatr Cardiol 2013;34(1):119-24.

İndeks‎: PubMed 22760694

DOI‎: 10.1007/s00246-012-0398-1

https://www.ncbi.nlm.nih.gov/pubmed/22760694 (yeni pencere açar)

Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. (yeni pencere açar)

Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.

Kaynak‎: Pediatr Hematol Oncol 2008;25(4):301-11.

İndeks‎: PubMed 18484474

DOI‎: 10.1080/08880010802016904

https://www.ncbi.nlm.nih.gov/pubmed/18484474 (yeni pencere açar)

Pıhtılaşma Faktörü Konsantreleri

Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (yeni pencere açar)

Cui Y, Hei F, Long C, Feng Z, Zhao J, Yan F, Wang Y, Liu J.

Kaynak‎: Artif Organs 2010;34(11):955-60.

İndeks‎: PubMed 21092037

DOI‎: 10.1111/j.1525-1594.2010.01148.x

https://www.ncbi.nlm.nih.gov/pubmed/21092037 (yeni pencere açar)

Plasma fibrinogen concentration is correlated with postoperative blood loss in children undergoing cardiac surgery. A retrospective review. (yeni pencere açar)

Faraoni D, Willems A, Savan V, Demanet H, De Ville A, Van der Linden P.

Kaynak‎: Eur J Anaesthesiol 2014;31(6):317-26.

İndeks‎: PubMed 24503704

DOI‎: 10.1097/EJA.0000000000000043

https://www.ncbi.nlm.nih.gov/pubmed/24503704 (yeni pencere açar)

Efficacy and safety of fibrinogen concentrate in surgical patients: a meta-analysis of randomized controlled trials. (yeni pencere açar)

Fominskiy E, Nepomniashchikh VA, Lomivorotov VV, Monaco F, Vitiello C, Zangrillo A, Landoni G.

Kaynak‎: J Cardiothorac Vasc Anesth 2016;30(5):1196-204.

İndeks‎: PubMed 27493092

DOI‎: 10.1053/j.jvca.2016.04.015

https://www.ncbi.nlm.nih.gov/pubmed/27493092 (yeni pencere açar)

Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial. (yeni pencere açar)

Galas FR, de Almeida JP, Fukushima JT, Vincent JL, Osawa EA, Zeferino S, Câmara L, Guimarães VA, Jatene MB, Hajjar LA.

Kaynak‎: J Thorac Cardiovasc Surg 2014;148(4):1647-55.

İndeks‎: PubMed 24951020

DOI‎: 10.1016/j.jtcvs.2014.04.029

https://www.ncbi.nlm.nih.gov/pubmed/24951020 (yeni pencere açar)

Four-factor prothrombin complex concentrates in paediatric patients—a retrospective case series. (yeni pencere açar)

Noga T, Bruce AA, Blain H, Nahirniak S.

Kaynak‎: Vox Sang 2016;110(3):253-7.

İndeks‎: PubMed 26509839

DOI‎: 10.1111/vox.12353

https://www.ncbi.nlm.nih.gov/pubmed/26509839 (yeni pencere açar)

Topikal Hemostatik (Kanama Durdurucu) İlaçlar

A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. (yeni pencere açar)

Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH.

Kaynak‎: Ann Surg 2010;251(2):217-28.

İndeks‎: PubMed 20010084

DOI‎: 10.1097/SLA.0b013e3181c3bcca

https://www.ncbi.nlm.nih.gov/pubmed/20010084 (yeni pencere açar)

Resternotomy in pediatric cardiac surgery: CoSeal initial experience. (yeni pencere açar)

Pace Napoleone C, Oppido G, Angeli E, Gargiulo G.

Kaynak‎: Interact Cardiovasc Thorac Surg 2007;6(1):21-3.

İndeks‎: PubMed 17669759

DOI‎: 10.1510/icvts.2006.141531

https://www.ncbi.nlm.nih.gov/pubmed/17669759 (yeni pencere açar)

Cerrahiye ya da Pıhtılaşma Bozukluğuna Bağlı Kanamanın Tespitinde Viskoelastik Testler

Utility of Sonoclot analysis and tranexamic acid in tetralogy of Fallot patients undergoing intracardiac repair. (yeni pencere açar)

Aggarwal V, Kapoor PM, Choudhury M, Kiran U, Chowdhury U.

Kaynak‎: Ann Card Anaesth 2012;15(1):26-31.

İndeks‎: PubMed 22234018

DOI‎: 10.4103/0971-9784.91477

https://www.ncbi.nlm.nih.gov/pubmed/22234018 (yeni pencere açar)

Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (yeni pencere açar)

Cui Y, Hei F, Long C, Feng Z, Zhao J, Yan F, Wang Y, Liu J.

Kaynak‎: Artif Organs 2010;34(11):955-60.

İndeks‎: PubMed 21092037

DOI‎: 10.1111/j.1525-1594.2010.01148.x

https://www.ncbi.nlm.nih.gov/pubmed/21092037 (yeni pencere açar)

Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. (yeni pencere açar)

Nakayama Y, Nakajima Y, Tanaka KA, Sessler DI, Maeda S, Iida J, Ogawa S, Mizobe T.

Kaynak‎: Br J Anaesth 2015;114(1):91-102.

İndeks‎: PubMed 25303988

DOI‎: 10.1093/bja/aeu339

https://www.ncbi.nlm.nih.gov/pubmed/25303988 (yeni pencere açar)